BioAdvance News Portfolio News Venatorx Pharmaceuticals

Venatorx Pharmaceuticals Appoints Tomas J. Heyman as Non-Executive Chairman

By WebmasterMarch 7, 2023November 1st, 2024No Comments

Venatorx Pharmaceuticals Appoints Tomas J. Heyman as Non-Executive Chairman

Dr. Michael Diem Steps Down from Board of Directors

Previous PostVESTECK, Inc. is pleased to announce the first in human use of several SUTURE-TIGHT devices
Next PostHanimune Therapeutics raises $3.3M, sets sights on first food allergy treatment product